📝 Resonance Specialties Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Resonance Specialties Ltd reported revenue of ₹33 crore for the quarter ended June 2026 (Q1 FY27), up 53.2% from ₹21 crore in the same quarter last year, and up 33.1% sequentially over the March 2026 quarter.
Net profit rose 252.4% year-on-year to ₹6 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹4.98.
Operating profit stood at ₹7 crore — an operating margin (OPM) of 22.9%, compared with 12.0% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Resonance Specialties Ltd posted revenue of ₹90 crore, a growth of 16.0% over FY25, with a net profit of ₹10 crore (up 58.1% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹102 crore with a net profit of ₹15 crore.
Valuation snapshot
At the current price of ₹156.80, 524218 has a market capitalisation of ₹188 crore and a trailing P/E of about 13.0.
Within the Specialty Chemicals industry, it is the 25th-largest of the 66 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 54.25%, domestic institutional investors (DIIs) 1.55%, public shareholders 44.19% of Resonance Specialties Ltd.